4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Rocket Pharmaceuticals, Inc. (RCKT) operates in the Biotechnology industry and is headquartered in Cranbury, United States with about 202 employees. Its market capitalization is roughly $375 million. In the fiscal year ended 2025-12-31, RCKT reported $0M in revenue and ($223M) in net income.
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($228M) | ($273M) | ($260M) | ($224M) | — |
| Net Income | ($223M) | ($259M) | ($246M) | ($222M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($48M) | ($44M) | ($52M) | ($68M) | ($64M) |
| Net Income | ($48M) | ($42M) | ($50M) | ($69M) | ($61M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $330M | $528M | $566M | $552M | — |
| Total Liabilities | $53M | $64M | $74M | $62M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive RCKT viewer.
About TickerBase · Data methodology & sources